Background and Purpose-Moyamoya angiopathy (MMA) is a rare cerebral vasculopathy outside of Asia. In Japanese patients, a vast majority of patients carry the founder p.R4810K variant in the RNF213 gene, and familial cases are around 10%. In European patients, data about familial occurrence are limited. The aim of this study was to characterize the clinical and molecular features of several European families with a parent-to-child transmission of MMA. Methods-Out of 126 MMA probands referred, we identified 113 sporadic probands and 13 familial probands. Segregation analysis showed a vertical parent-to-child pattern of inheritance in the families of 5 of these probands. All 5 families were of German or Dutch ancestry. We investigated the clinical features of affected members and used whole-exome sequencing to screen RNF213 and 13 genes involved in Mendelian MMA and to identify genes recurrently mutated in these families. Results-Twelve affected MMA patients were identified, including 9 females and 3 males. Age at clinical onset ranged from 11 to 65 years. In 3 of 5 families, associated livedo racemosa was found. We did not detect any deleterious variants in the 13 known MMA genes. RNF213 rare missense variants predicted to be pathogenic were detected in all affected members of 2 of these families, as well as 2 candidate variants of the PALD1 gene. Conclusions-Nonsyndromic MMA was identified in 5 European families, including 2 to 3 clinically affected cases segregating with a parent-to-child pattern of inheritance in each family. Molecular screening detected rare deleterious variants within RNF213 and PALD1 in all affected members of 2 of these 5 families, as well as in some clinically unaffected members. Altogether these data raise the difficult and, to date unanswered, question of the medical indication of presymptomatic screening.
M oyamoya angiopathy (MMA) is characterized by a progressive stenosis of the intracranial internal carotid arteries and their proximal branches within the circle of Willis, associated with the development of thin collateral vessels (Moyamoya vessels). 1 This rare condition (prevalence around 6/100 000 in Japan and Korea and about 10× less in Western countries) leads to ischemic and hemorrhagic stroke in both children and adults. Its pathophysiology is to date unknown. Two entities can be distinguished; Moyamoya disease (MMD) refers to the isolated form of angiopathy, whereas the term Moyamoya syndrome (MMS) is used to define MMA because of an acquired condition or a condition associated with other systemic symptoms.
A genetic determinism has long been suspected in MMD, based on the strong ethnicity-related effect and a prevalence of familial cases close to 10%. 2 In East Asian countries, the RNF213 gene encoding for an E3 ubiquitin ligase has been established as a major susceptibility gene in MMD, with 80% of MMD patients in Japan carrying the missense p.R4810K variant located in this gene. 3, 4 A significant enrichment in other rare RNF213 variants has recently been demonstrated in European MMA patients. 5, 6 Nevertheless, despite this strong association, the low penetrance of RNF213 mutations strongly suggests that additional factors are required to develop this angiopathy.
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However, several Mendelian diseases are known to be responsible for MMS. 7 However, mutations in these Mendelian MMS-causing genes are involved in a small proportion of MMA patients, reflecting the strong genetic heterogeneity of this angiopathy. Such mutations usually lead to highly recognizable MMS (eg, MMA and achalasia in GUCY1A3 mutated patients). 8 Genetic screening of these MMS-causing genes was until recently routinely performed only in patients showing suggestive symptoms of these Mendelian diseases associated with MMA. Emerging data have shown that mutations in these MMS-causing genes can also lead to isolated MMA, 9, 10 raising the question of the importance of routine diagnostic screening in patients without any overt systemic symptom suggestive of an already known Mendelian disease.
Altogether, a vast majority of MMA cases remains, however, of unknown cause, notably in whites. Few multigenerational MMA families have been described to date Caucasians, 5, 11, 12 (Table I in the Data Supplement). The proportion of familial cases in Caucasians is unknown. In this study, we report clinical and molecular data from 5 European families with a parent-to-child transmission of MMA, aiming to better characterize specificities of this subgroup.
Methods
Because of the sensitive nature of the data collected for this study, requests to access the dataset from qualified researchers trained in human subject confidentiality protocols may be sent to Markus Kraemer at Krupp Hospital, Essen.
Recruitment and Clinical Investigations
European vertical multiplex families reported here were referred to the Alfried Krupp Hospital, Essen, Germany. They were part of a large multiethnic cohort of 126 MMA unrelated families referred to the molecular genetics department at Lariboisière hospital (Paris, France). Diagnosis of MMA was made according to the Research Committee on Spontaneous Occlusion of the Circle of Willis published guidelines. 2, 13 In all 126 patients, a comprehensive clinical and radiological assessment did not reveal evocative features of known inherited or acquired MMS. This cohort comprised 113 sporadic cases (and some of their unaffected relatives) and 13 multiplex families. 96 of these probands (76 %) were European (mainly from France and Germany), the remaining ones being essentially Asian and North African. All the 13 multiplex families were European.
We included in the present series all 5 families showing a parentto-child transmission. Four of them were of German ancestry, and 1 family was of Dutch origin. The study was approved by the Ethics Committee of the University of Duisburg-Essen. All participants gave their written informed consent.
All available affected members of these 5 families were followed up with assessment of detailed medical history, family history, neurological and physical examination, magnetic resonance (MR) imaging (MRI) with MR-angiography (MRA), as well as duplex ultrasound studies. They were laboratory screened for thyroid, renal, liver, and coagulation abnormalities. All index patients underwent cerebral angiography and almost all got cerebrospinal fluid analysis, laboratory screening for vasculitis, transoesophageal echocardiography, 24-hours ECG, and ophthalmologic examination. Genealogical trees of these families are shown in Figure 1 . Clinical features are shown in the results section.
Genetic Analysis
To assess the putative genetic cause of those similar and unresolved cases, a whole-exome sequencing was performed in probands and MMA-affected relatives in these 5 multiplex families (Figure 1 ).
We first drafted a list of the genes involved in known mendelian MMS on the basis of previously published data. This panel included 13 genes, PTPN11, SHOC2, PCNT, NF1, HBB, CBL, JAG1, SMARCAL1, SAMHD1, ACTA2, GUCY1A3, CCER2, and BRCC3/ MTCP1 (Table II in the Data Supplement). In a second step, we screened these 13 MMS-related genes and the RNF213 gene using whole-exome sequencing data from the affected members of these 5 families. Variants' filtering was performed as described in on-line Methods in the Data Supplement. To identify novel candidate genes, we then performed an exome-wide analysis of these 5 families. Given the dominant hypothesis in these multigenerational families and the rarity of MMA, we only considered heterozygous variants (1) shared by every affected member in a given family, (2) showing a minor allele frequency below 0.01% in public databases ExAC, Exome Variant Server, and 1000Genomes and absent in the pool of internal controls, and (3) predicted to be deleterious after in silico analyses. A candidate gene was defined as a gene carrying a candidate mutation in at least 2 of these 5 families. In families where a candidate gene was identified, healthy relatives were genotyped when available (using whole-exome sequencing data if available or Sanger sequencing).
For further information, please see Data Supplement.
Results
Clinical Description of the 5 European Vertical Multiplex Families
Family trees of the 5 families are shown in Figure 1 . Main clinical, biological, and imaging features of the probands and affected relatives are summarized in Table III in the Data Supplement. Cerebral angiograms, MRI pictures, and skin photographs are presented in Figure I in the Data Supplement.
M010 Family
A 56-year-old Dutch proband (M010-5, proband) was referred to Alfried Krupp hospital (partially reported in Guey et al, 2017 5 ). She actually felt healthy, but when she was 41-yearold, she suffered from recurrent paresis of right arm and limb for about 3 weeks. Furthermore, she reported recurrent vertigo and migraine in the past. She asked for exclusion of MMA because of affected sister (M010-7) and daughter (M010-10). Her neurological status was normal. Physical examination revealed livedo racemosa ( Figure I in the Data Supplement). Duplex sonography and later conventional angiography revealed bilateral MMA ( Figure I1a in the Data Supplement). She was followed up conservatively and experienced no further stroke or transient ischemic attacks up to July 2018.
Some years earlier, her 10-year-old daughter (M010-10) suffered from middle cerebral artery (MCA) stroke in the age of 10 years. She was diagnosed with bilateral MMA in the Netherlands ( Figure I1b in the Data Supplement). She underwent bilateral bypass surgery shortly after diagnosis.
The sister of the proband (M010-7) had previously been diagnosed with MMA (not shown in Figure I in the Data Supplement) in the age of 13 years after experiencing stroke. She underwent bypass surgery because of recurrent ischemic attacks at the age of 21. This sister died from cerebral hemorrhage in the age of 30 years.
Some years later, another sister of the proband (M010-4) had been diagnosed with multiple sclerosis and bipolar disorder. She died in the age of 52 years after febrile infection.
The mother of the proband (M010-2) suffered from stroke and vascular dementia in the age of over 70.
M019 Family
A 27-year-old German male patient (M019-7, proband) suffered from left-sided stroke, which was so extreme that he had to undergo decompressive hemicraniectomy. At the time of diagnosis of MMA, MRI also showed right-sided postischemic gliosis (partially reported in Guey et al, 2017 5 ). Conventional cerebral angiography revealed bilateral MMA with involvement of both sided posterior cerebral arteries ( Figure I2a in the Data Supplement). Because of hemodynamic insufficiency, he underwent bypass surgery of the left side. His medical status remained disabled with spastic rightsided hemiparesis and residual aphasia.
The 65-year-old mother of the proband (M019-3) suffered from recurrent hemiparesis of the left side during rehab after surgery for knee prothesis. She was diagnosed having postoperative anemia. Her medical history was significant for gonarthrosis, arterial hypertension, mild adiposity, depression, hypothyreosis, and right-sided hip joint prosthesis 2 years before. MRI showed acute diffusion restricted ischemic lesions in the right-sided MCA territory and old ischemic gliosis in the left MCA territory. Cerebral angiography confirmed bilateral MMA ( Figure I2b in the Data Supplement). Two months later, she once again suffered from stroke presenting with dysarthria, accented hemiparesis, and somnolence. She underwent bypass surgery of the right hemisphere. She remained disabled.
The 36-year-old brother of the proband (M019-6) who is healthy requested MRI and angiography. Both examinations excluded MMA (not shown in Figure I in the Data Supplement). His 4-year-old daughter was also excluded having MMA based on MRA.
A maternal uncle of the proband (M019-4) died early of unknown cause. No juvenile strokes were known in other family members.
The other maternal uncle of the proband (M019-5) did not complain neurological problems. His medical history was positive for varicosis and mild arterial hypertension. He underwent MRA, which showed asymptomatic occlusion of left-sided anterior cerebral artery without hints of stroke ( Figure I2c in the Data Supplement). His 35-year-old daughter and his 33-year-old son were healthy, and their MRA had been normal.
M039 Family
A 44-year-old German female patient (M039-3, proband) was diagnosed with bilateral MMD after presenting a stroke in the left MCA territory leading to mild motor aphasia and mild neuropsychological impairment. Moreover, she reported recurrent transient bilateral prickling episodes over the last 5 months. Past medical history was unremarkable except for thyroid surgery and dry skin. She has no vascular risk factors, except a mild arterial hypertension. Physical examination 
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April 2019 revealed livedo racemosa (not shown in Figure I in the Data Supplement), severe dry skin, and crinkly hands. Her family history was negative for juvenile stroke to date. Conventional angiography showed a typical MMA ( Figure I3a and I3b in the Data Supplement). In addition to the left-side stroke, brain MRI showed right-sided gliosis. Hemodynamic insufficiency was proven by MR perfusion and transcranial duplex sonography (TCD). The cell count in the cerebrospinal fluid was marginally elevated with 7 cells/mm 3 . Serum autoimmune and coagulation tests were normal. A brain biopsy allowed to rule out a cerebral vasculitis. She underwent bilateral bypass surgery and remained stable during follow-up up to 7 years.
Even though the family history did not point to a familial disease, we performed TCD in her 2 children and her siblings. At the scheduled appointment for the duplex sonography, the 16-year-old daughter (M 039-8) reported that she had been having problems walking for the past 6 days. Although painless, she and her family assumed a lumbar disc herniation and did not consult a physician. MRI revealed diffusion restricted ischemic lesions in the right anterior cerebral artery and MCA territories. MRI and conventional angiography documented typical bilateral but right accentuated MMA with hemodynamic insufficiency ( Figure I3c in the Data Supplement). Focal seizures and chronic headache further complicated her medical course. She had no vascular risk factor. Livedo racemosa was found at physical examination (not shown Figure  I in the Data Supplement). Because of an embolic infarction pattern on the diffusion-weighted MRI and the presence of High-Intensity Transient Signals in the right MCA on TCD, a transoesophageal echocardiography and a long-time ECG were performed and revealed no cardiac cause of embolism. Biological assessment only revealed heterozygous factor V Leiden mutation. Cerebrospinal fluid, as well as autoimmune serum, studies were normal. Aortic MRI was also normal. Her medical course was further complicated by chronic vomiting and gastric ulcer. We found mild cardiac insufficiency of the stomach and fructose intolerance. Esophageal manometry and barium meal examination were normal. She was treated by antiplatelet drugs and right-sided bypass surgery, performed at the age of 17 years.
M211 Family
A German male patient (M221-6 proband) was diagnosed with bilateral MMD at the age of 46. MMD was revealed by a stroke in the left MCA territory leading to a right-sided hemiparesis and aphasia. He also suffered from chronic migraine. His family history was negative for juvenile stroke to date. Conventional cerebral angiography showed a typical bilateral MMA ( Figure I4a and I4b in the Data Supplement). He underwent bilateral bypass surgery. Unfortunately, relapse occurred with bilateral stroke and intracranial hemorrhage of the right thalamus when he was 52 and 61 years old. His neurological status was even worse with spastic, ataxic hemiparesis, impaired fine motor skills on the left side, massive motor aphasia, and significant neuropsychological impairment. He presented cardiovascular risk factors, including mild high blood pressure, mild obesity, high cholesterol level, and tobacco consumption. Imaging performed when 57-year-old showed an evident extracranial atherosclerosis, with a 50% stenosis of the left extracranial internal carotid arteries and occlusion of the left extracranial vertebral artery. When 63 years old, he presented a complete occlusion of the extracranial left internal carotid arteries and an occlusion of the basilar artery, complicated by cerebellar infarction.
The proband's daughter (M221-8) was diagnosed with bilateral MMD at the age of 21, revealed by a large stroke of the right MCA territory, leading to a mild hemiparesis, fine motor skill impairment, hemianopia, and neuropsychological disorders. Over the years, she presented transient neurological symptoms, such as vertigo, loss of gait, and numbness, and suffered from headache. In the age of 39 years, a conventional angiography confirmed a typical bilateral MMA with involvement of the right-sided posterior cerebral artery ( Figure I4c and I4d in the Data Supplement). Perfusion studies showed reduced cerebral perfusion. She had no cardiovascular risk factors. General examination revealed a congenital anisocoria, and she complained of irritable bowel syndrome and bladder weakness. She underwent extensive explorations, including bladder sonography, barium meal examination, gastroscopy, and MRI of the aorta, which all were unremarkable. Furthermore, coagulation and autoimmune antibody blood profile were normal. She then underwent bilateral direct bypass surgery, leading to an improvement of her general condition. No new events occurred during further follow-up.
The proband's son (M221-9), born of a second marriage, was also diagnosed with bilateral MMD at the age of 23 revealed by a stroke in the left MCA territory leading to aphasia. Angiography documented a typical MMA ( Figure I4e and I4f in the Data Supplement). Despite heavy hemodynamic insufficiency documented by TCD, he refused bypass surgery. No comorbidity was noticed at general examination.
M261 Family
A German female patient (M261-4, proband) was diagnosed with unilateral MMA at the age of 52, after presenting a stroke in the left MCA territory. She further presented with transient ischemic attack with aphasia. Her past medical history revealed a birth at premature term and occurrence of 2 deep vein thromboses after long-lasting immobilization and pulmonary embolism during post-partum period. Her family medical history revealed that her brother died at the age of 65 years because of stroke and that her mother had a stroke when 86 years old. She presented cardiovascular risk factors, including mild arterial hypertension and mild obesity. Physical examination showed livedo racemosa ( Figure I in the Data Supplement). MRI, TCD, and conventional angiography documented a unilateral MMA; no sign of extracranial arteriosclerosis was observed ( Figure I5a in the Data Supplement). Screening for thrombophilia was negative, but blood profile revealed elevated antinuclear antibodies (1: 640). She suffered from autoimmune thyroiditis. Cerebrospinal fluid analysis was normal. Because of hemodynamic insufficiency, she underwent bypass surgery, after which she remained stable.
The younger daughter of the proband (M261-9) was diagnosed with bilateral MMA at the age of 11 years, revealed by recurrent transient ischemic attack and stroke. Her past medical history revealed a premature birth at 30 weeks of gestation, a persisting foramen ovale, and a persisting ductus arteriosus Botalli that spontaneously resolved. Angiography documented typical bilateral MMA ( Figure I5b in the Data Supplement). Physical examination revealed mild obesity and livedo racemosa ( Figure I in the Data Supplement). Serum studies were completely normal. She underwent bypass surgery at the age of 12 years, after which she remained stable.
The older daughter of the proband (M261-8) was also born prematurely, 11 weeks before the calculated birth date and suffered from congenital left spastic hemiparesis. MRI performed when 21 years old showed asymmetrical dilation of the lateral ventricle, pointing to right perinatal cerebral hemorrhage. MRA found no MMA.
Genetic Analysis
Molecular screening of the 13 genes involved in known Mendelian MMS did not detect any deleterious candidate variant in those 5 multiplex families.
RNF213 screening revealed 2 distinct rare heterozygous missense variants in 2 out of the 5 families. The p.Ala3927Thr variant was identified in the M010 family and the p.Pro4033Leu variant in the M019 family. Both variants are located in a C-terminal hotspot encompassing the RING-finger domain that has been demonstrated to be highly associated with MMA in white patients. 5 One of them, the p.Pro4033Leu variant, directly affects the RING-finger domain. In the 2 RNF213 mutated families, all affected members carried the RNF213 variant. However, in the M019 family, 3 carriers were unaffected, and 1 presented with steno-occlusive angiopathy but without fulfilling criteria for MMA, in accordance with the known incomplete penetrance of RNF213 variants.
Exome-wide analysis led to identification of 21 to 47 rare heterozygous candidate variants per family (Table IV in the Data Supplement). In addition to RNF213, PALD1 was the sole gene showing a candidate variant in ≥1 family (Figure 2) . The p.Ser34Arg missense variant was identified in the M010 family and the p.Glu705Asp variant in the M019 family (Table) . Interestingly, the 2 families mutated in PALD1 were also mutated in RNF213. In M010 and M019 families, all affected members carried the PALD1 variant. However, as observed for RNF213 variants, several unaffected members carried the variant (3 in the M010 family and 2 in the M019 family). Recurrence analysis in the 121 other probands of the MMA cohort identified several additional candidate variants in RNF213 detailed in Guey et al 5 but did not find any additional candidate variant in PALD1.
Discussion
Here, we report the largest case series of European familial MMA showing a multigenerational pattern of inheritance. Strikingly, in addition to the vertical transmission of the MMA, these 5 families showed some common clinical features.
Firstly, we observed a clear female preponderance (9 affected females versus 3 males only), and an earlier age of MMA-onset among offspring as compared to parents, as usually described in Asian MMA families.
14 Secondly, a livedo racemosa was reported in 3 out of the 5 families (M010, M039, and M261). This finding could reflect a global vasomotor dysfunction. Indeed, livedo racemosa reflects a blood stasis in the dermal venules because of a decrease of the blood flow by regional vasoconstriction or by arteriolar occlusion. 15 Livedo racemosa is known to be frequently associated with autoimmune conditions and has been described in some genetic forms of MMA as well. 16 Importantly, a dysimmune thyroiditis has been observed in 2 out of the 4 MMA patients showing a livedo (M039-3 and M261-4). However, the above-mentioned features like livedo racemosa and autoimmune thyroiditis are unspecific. From a clinical point of view, it is noteworthy that there were no obvious clinical hints that could help identifying relatives of patients with MMA who were at risk to develop MMA in these 5 families. Contrary to some other familial diseases, not all affected members were diagnosed in young age, for example, M019-3 with 56 years and M261-4 with 52 years. In the absence of previous MRA data, it is not possible to determine whether those patients developed MMA late or if they were asymptomatic carriers earlier. This raises questions regarding familial screening using noninvasive methodologies (such as TCD). The study of Han et al 17 found that noninvasive transcranial ultrasound has a high diagnostic agreement with MMA in family screening for MMA. The risk of disabling stroke or hemorrhage in MMA may argue for early detection, providing that this early detection leads to a good benefit/risk ratio for the patient. However, the missing data about natural history and risk for stroke and hemorrhage in asymptomatic whites and the uncertainty on what should be done once presymptomatic screening has been performed could be seen as an argument against family screening. Further considerations on presymptomatic screening can be found in the Discussion section in the Data Supplement. Observational data from Europe concerning surgery 18, 19 and conservative treatment possibilities could argue for systematic familial screening, at least in families known to include at least 2 clinically affected cases. Indeed, antiplatelet therapy is thought to prevent embolic stroke and revasculating therapy, and other therapies like blood pressure management are suspected to prevent hemodynamic stroke also in Europeans. 11 However, this case study is not able to argue for or against family screening in asymptomatic relatives of a sporadic case. To summarize, additional and rigorous studies of the natural history in asymptomatic European patients would be needed to evaluate precisely the benefit/risk ratio of asymptomatic relatives screening.
The use of whole-exome sequencing to screen a given list of relevant genes is a cost-and time-effective technique when dealing with a highly heterogeneous disease, especially when mutations in distinct genes can lead to the same phenotype. 20 Indeed, we previously showed that CBL, a gene known to be associated with MMA in rare patients with Noonan-like syndrome, was also associated with MMA in patients that do not show the usual syndromic Noonan-like phenotype. 9 These data suggested that it might be of interest to check this gene, as well as other MMS genes in MMA patients, even in the absence of characteristic syndromic features. However, our genetic screening did not identify causative variants in Moyamoya known genes in these 5 families. A larger study focusing on this gene panel will help to assess its diagnostic rate in consecutive MMA patients.
In M010 and M019 families, all affected relatives carried a rare variant in the RNF213 susceptibility gene. Rare missense variants of RNF213 have previously been demonstrated to be associated with the development of MMA in European patients. 5, 6 Of note, M010 and M019 probands had previously been included in a collapsing gene-based burden test study that firmly established the association between MMA and RNF213 variants, especially when located in a C-terminal hotspot encompassing the RING-finger domain. 5 Missense p.A3927T and p.P4033L variants detected in these 2 families are included in the mutational European hotspot, highly suggesting that they are causative variants. In RNF213 mutated multiplex families, including M010 and M019 families, the penetrance of MMA in mutated relatives is usually incomplete, around 25%. 5 This finding highly suggests that additional genetic or environmental factors are needed to develop MMA.
Under the hypothesis of a possible dominant inheritance, we searched for candidate genes that would be mutated in at least 2 of these families. We did not find a unique candidate gene mutated in all 5 families but found a gene mutated in 2 families that was not previously involved in Moyamoya, PALD1. Among the 121 additional unrelated MMA probands who do not belong to multigenerational families, none showed a candidate variant in PALD1. Thus, PALD1 should be considered, to date, only as a putative Moyamoya gene until additional mutated cases are identified. These data might also suggest that PALD1 mutations are involved only in multigenerational familial forms of MMA, but this has to be confirmed by further studies. Indeed, at this point, the recurrence of PALD1 mutations in 2 of these families is not sufficient to firmly establish the role of this gene in MMA. To establish the pathogenicity of the identified variants will require functional analyses. PALD1 encodes a recently described cytoplasmic protein with 4 predicted phosphatase domains. Several independent groups have identified PALD1 as a vascular enriched gene. [21] [22] [23] [24] Some recent experimental data in mice suggest that this protein is involved in endothelial cell survival and proliferation. 25 The pathogenicity of those PALD1 variant remains to be elucidated in this context. Interestingly, rare candidate variants of RNF213 and PALD1 have been identified within the same 2 families (M010 and M019), leading to the hypothesis that variants in these 2 genes might act synergistically, although additional experiments would be required before any firm conclusion can be established.
Recent data strongly suggest that the genetic architecture of MMA in Europeans is complex and might involve numerous genes, each contributing to a small proportion of patients. This might also be true for multigenerational families. Increasing the number of multigenerational European MMA families and using approaches based on gene-network burden studies will probably help to assess the role of PALD1 and to identify new MMA genes in the future.
